Home
About IRMND
News
Seminars
Articles
Instruction
Contact us
 
 
 
 
 
 
 

Study on MRI Changes in Phenylketonuria in Patients Referred to Mofid Hospital/Iran
Vol 8, No 2 (2014): Iran J Child Neurol. Spring 2014 
 
You can see full article in below link:
 

http://journals.sbmu.ac.ir/index.php/ijcn/article/view/5691/5253
 
 
Parveneh KARIMZADEH, Farzad AHMADABADI*, Narjes JAFARI, Fakhreddin SHARIATMADARI, Hamid NEMATI, Adel AHADI, Sanaz KARIMI DARDASHTI, Mehrdad MIRZARAHIMI, Zahra DASTBORHAN, Javad ZARE NOGHABI 
 
==========
How to Cite This Article: Karimzadeh P, Ahmadabadi F, Jafari N, Shariatmadari F, Nemati H, Ahadi A, Karimi Dardashti S, Mirzarahimi M, Dastborhan Z, Zare Noghabi J. Study on MRI Changes in Phenylketonuria in Patients Referred to Mofid Hospital. Iran J Child Neurol. 2014 Spring 8(2):53-56 
========== 


 
Abstract
Objective
Phenylketonuria is one of the most common metabolic disorders and the first known cause of mental retardation in pediatrics. As Screening for phenylketonuria (PKU) is not a routine neurometabolic screening test for neonates in Iran, many PKU cases may be diagnosed after developing the clinical symptoms. One of the findings of PKU is myelination disorders, which is seen as hypersignal regions in T2-weighted (T2W) and FLAIR sequences of brain MRI. The aim

of our study was to assess MRI changes in PKU patients referred to Mofid Children's Hospital, 2010-2011.


Materials & Methods
We studied all PKU cases referred to our clinic as a referral neurometabolic center in Iran for brain MRI and assessed the phenylalanine level at the time of Imaging. The mean phenylalanine level (in one year), clinical manifestations,
and MRI pattern based on Thompson scoring, were evaluated.


Results
The mean age of our study group was 155±99 months and the mean diagnosis age was 37±27.85 months. There were 15 patients with positive and 15 with negative family history. The mean phenylalanine level at the time of imaging was 9.75±6.28 and the mean 1 year phenylalanine level was 10.28±4.82. Seventy percent of our patients had MRI involvement, in whom 20% showed atrophic changes, in addition to white matter involvement. Based on modified Thompson scoring, the score for our study group was 4.84.
The maximum involvement in MRI was in occipital region, followed by parietal, frontal, and temporal zones. There was not any correlation between MRI score and patients' age. But we found significant relationship between MRI score and
the age of regimen cessation. No correlation was seen between phenylalanine level (at the time of Imaging) and MRI score. But there was a relationship between mean 1 year phenylalanine level and MRI score.

Conclusion
According to the results of this study, brain MRI and white matter involvement can be used for evaluation of long-term control of phenylalanine level in PKU cases.

Keywords

Phenylketonuria; MRI; Thompson scor

 

 
 
 
 
Copyright © IRNMD 2013. All Rights Reserved